Question

Difficulty: EasyDiagnostic Workup and Test Sequencing

A 48-year-old man presents to the primary care clinic reporting that his wedding ring no longer fits and his shoe size has increased significantly over the past two years. He also notes excessive sweating and a recent onset of heavy snoring. Physical examination reveals coarse facial features, macroglossia, a prominent jaw, and enlarged, doughy hands. The physician strongly suspects an excess of growth hormone. Arrange the following diagnostic steps in the most appropriate sequential order for the workup of this patient's condition, from the initial screening test to final anatomic localization.

  1. 1Measurement of serum insulin-like growth factor 1 (IGF-1) level
  2. 2Measurement of serum growth hormone after an oral glucose load
  3. 3Magnetic resonance imaging (MRI) of the pituitary gland

Answer

The correct diagnostic sequence for suspected acromegaly is to first screen with a serum IGF-1 level, then confirm the diagnosis dynamically with an oral glucose suppression test, and finally localize the adenoma anatomically with a pituitary MRI.
The standard diagnostic pathway for acromegaly relies on a sequential, tiered approach designed to prevent false positives and unnecessary surgeries. It strictly begins with IGF-1, a stable surrogate marker of average GH levels. If elevated, an oral glucose tolerance test provides definitive biochemical proof by demonstrating autonomous GH production that fails to suppress with a glucose load. Only after the disease is biochemically proven should a pituitary MRI be obtained to anatomically define the tumor for surgical resection.

Step-by-Step Solution

1
Identify the most reliable initial screening test.
Measurement of serum insulin-like growth factor 1 (IGF-1) level is placed first.
IGF-1 provides a reliable, integrated assessment of growth hormone secretion over time, avoiding the pitfalls of pulsatile GH release.
2
Identify the definitive confirmatory test.
Measurement of serum growth hormone after an oral glucose load is placed second.
Once the screening test is abnormal, biochemical confirmation is strictly required via dynamic testing to demonstrate the failure of growth hormone suppression.
3
Select the imaging modality for anatomic evaluation.
Magnetic resonance imaging (MRI) of the pituitary gland is placed third.
Anatomic imaging must only be performed after definitive biochemical confirmation to avoid the discovery of confounding pituitary incidentalomas.

Key Concept

The diagnostic workup for acromegaly follows a strict, tiered sequence: initial biochemical screening with IGF-1, followed by dynamic biochemical confirmation with an oral glucose tolerance test, and finally anatomic localization with pituitary MRI.
Rate this question